Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELER phase III study of letrozole with or without standard chemotherapy in first-line treatment of metastatic breast cancer
2005-001701-26Phase 3Completed
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole in breast cancer (2 arms), sponsored by Central European Society for Anticancer Drug Research. Primary endpoint: Time to progression. Started Jan 2006; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001701-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001701-26.